Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Hamaoka

Showing results (111-120 of 413) with videos related to

Pageof 42
Sort By:
Research in Immunology|September 1, 1995
A sequence of cellular and molecular events involved in IL12-induced tumour regressionH Fujiwara, J P Zou, S Herrmann, et al.
The Journal of Molecular and Cellular Immunology : JMCI|January 1, 1987
Polyclonal B-cell activation by a B-cell differentiation factor B151-TRF2. IV. B151-TRF2-responsive F1 B cells consist of two separate populations capable of recognizing only one of the parental I-A products expressed on B cellsY Takaháma, S Ono, L H Glimcher, et al.
National Institute of Animal Health Quarterly|January 1, 1981
Role of delayed type hypersensitivity in mice inoculated with Staphylococcus aureus (Strain CH-91)S Takeuchi, Y Nakajima, T Hamaoka, et al.
Japanese Journal of Cancer Research : Gann|September 1, 1985
Enhanced induction of tumor-specific Lyt-1+2- T cell-mediated protective immunity by in vivo administration of interleukin 1Y Izumi, T Tsuchida, K Okuno, et al.
Biochemistry|February 20, 1979
New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugatesF T Liu, M Zinnecker, T Hamaoka, et al.
International Immunology|January 1, 1990
B-B cell interaction involved in polyclonal B cell activation is restricted by I-A but not by I-E moleculesY Takahama, S Ono, K Ishihara, et al.
Japanese Journal of Cancer Research : Gann|February 1, 1992
Tumor-specific T cell lines: capacity to proliferate and produce interleukin 2 in response to various forms of tumor antigensJ Shimizu, T Suda, T Katagiri, et al.
Radiology Case Reports|July 10, 2020
Novel method for endovascular fenestration using radiofrequency transseptal needle for aortic dissection with malperfusion syndromeN Yagi, T Nakagami, S Yamaguchi, et al.
Immunology|August 1, 1976
Preferential generation of killer or helper T-lymphocyte activity directed to the tumour-associated transplantation antigensH Fujiwara, T Hamaoka, K Teshima, et al.
Gan|July 1, 1984
Tolerance induction in tumor-specific effector T cells by presensitization with tumor antigens via the intragastric routeT Hashimoto, K Okuno, T Tsuchida, et al.
Pageof 42

Showing results (111-120 of 413) with videos related to

Sort By:
Pageof 42
Research in Immunology|September 1, 1995
A sequence of cellular and molecular events involved in IL12-induced tumour regressionH Fujiwara, J P Zou, S Herrmann, et al.
The Journal of Molecular and Cellular Immunology : JMCI|January 1, 1987
Polyclonal B-cell activation by a B-cell differentiation factor B151-TRF2. IV. B151-TRF2-responsive F1 B cells consist of two separate populations capable of recognizing only one of the parental I-A products expressed on B cellsY Takaháma, S Ono, L H Glimcher, et al.
National Institute of Animal Health Quarterly|January 1, 1981
Role of delayed type hypersensitivity in mice inoculated with Staphylococcus aureus (Strain CH-91)S Takeuchi, Y Nakajima, T Hamaoka, et al.
Japanese Journal of Cancer Research : Gann|September 1, 1985
Enhanced induction of tumor-specific Lyt-1+2- T cell-mediated protective immunity by in vivo administration of interleukin 1Y Izumi, T Tsuchida, K Okuno, et al.
Biochemistry|February 20, 1979
New procedures for preparation and isolation of conjugates of proteins and a synthetic copolymer of D-amino acids and immunochemical characterization of such conjugatesF T Liu, M Zinnecker, T Hamaoka, et al.
International Immunology|January 1, 1990
B-B cell interaction involved in polyclonal B cell activation is restricted by I-A but not by I-E moleculesY Takahama, S Ono, K Ishihara, et al.
Japanese Journal of Cancer Research : Gann|February 1, 1992
Tumor-specific T cell lines: capacity to proliferate and produce interleukin 2 in response to various forms of tumor antigensJ Shimizu, T Suda, T Katagiri, et al.
Radiology Case Reports|July 10, 2020
Novel method for endovascular fenestration using radiofrequency transseptal needle for aortic dissection with malperfusion syndromeN Yagi, T Nakagami, S Yamaguchi, et al.
Immunology|August 1, 1976
Preferential generation of killer or helper T-lymphocyte activity directed to the tumour-associated transplantation antigensH Fujiwara, T Hamaoka, K Teshima, et al.
Gan|July 1, 1984
Tolerance induction in tumor-specific effector T cells by presensitization with tumor antigens via the intragastric routeT Hashimoto, K Okuno, T Tsuchida, et al.
Pageof 42